Greg Curhan joined FLG in 2020 with over 35 years of operational, financial, capital markets and strategic advisory experience in various sectors including Investment Banking, Medical Device/Life Sciences, Internet, Clean Technology, and Investment/Wealth Management. As CFO, Greg has managed Finance, Legal HR, and Investor Relations functions for Public and Private companies. He has raised equity and debt capital for both private and public companies, completed a successful IPO, and executed M&A transactions both acquiring and divesting companies. He has also served in CEO, President and Board of Director capacities. In July 2020, Greg was appointed to the Advisory Board at Specific Diagnostics as the company prepares to launch its Reveal rapid susceptibility testing system in Europe.
Sourced facts
- Role
Partner
Greg Curhan- Location
Not disclosed
Greg Curhan- Background
Greg Curhan joined FLG in 2020 with over 35 years of operational, financial, capital markets and strategic advisory experience in various sectors including Investment Banking, Medical Device/Life Sciences, Internet, Clean Technology, and Investment/Wealth Management. As CFO, Greg has managed Finance, Legal HR, and Investor Relations functions for Public and Private companies. He has raised equity and debt capital for both private and public companies, completed a successful IPO, and executed M&A transactions both acquiring and divesting companies. He has also served in CEO, President and Board of Director capacities. In July 2020, Greg was appointed to the Advisory Board at Specific Diagnostics as the company prepares to launch its Reveal rapid susceptibility testing system in Europe.
Greg Curhan
Sources
- Greg Curhan · FLG Partners · Accessed 2026-10-07